Skip to main content

Table 3 Clinical profiles of the patients whose plasma samples were analyzed by ELISA

From: Differential proteomic analysis of virus-enriched fractions obtained from plasma pools of patients with dengue fever or severe dengue

  Colombian Patients Cambodian Patients
  DF (n = 15) DS (n = 15) P-value DF (n = 23) DS (n = 26) P-value
Age, average ± SD (years) 29.3 ± 0.52 28.3 ± 0.5 ns 8.6 ± 0.38 7.3 ± 0.45 ns
% male 60 % 53 % ns 56 % 35.6 % ns
Sampling (day after onset) 3.06 2.37 ns 2.6 3.2 ns
Weight, average ± SD (Kg) 60.2 ± 8.6 50.3 ± 15.6 ns 20.48 ± 0.93 18.86 ± 0.98 ns
Total cholesterol (g/L) 1.44 ± 5.4 1.29 ± 10.1 0.03 1.28 ± 0.05 0.92 ± 0.046 <0.0001
Aspartate aminotransferase (IU/L) 90.2 ± 9.75 142.7 ± 29.8 0.001 133.3 ± 23.18 302.5 ± 50.7 0.0043
Alanine aminotransferase (IU/L) 69.7 ± 11.4 90.8 ± 24.5 ns 66.9 ± 13.4 106.3 ± 21.2 ns
Viral load (copy/mL) 4.05 × 106 ± 3.5 4.1 × 107 ± 5.22 0.006 7.1 108 ± 6 2.06 108 ± 2 ns
Positive Tourniquet test 8/15 (60 %) 10/15 (66 %) ns 19/23 (82 %) 18/26 (82.6 %) ns
Hepatomegaly on ultrasound na na - 8/12 (66 %) 16/26 (61.5 %) ns
Serotype 1-2-3 1-2-3 - 1 1 -
Secondary dengue infection 15 (100 %) 15 (100 %) - 23 (100 %) 26 (100 %) -
Comorbidity 0 (0 %) 0 (0 %) - 0 (0 %) 0 (0 %) -
  1. IU international units, ns not significant, na not applicable
  2. Chi-square or Mann–Whitney tests were used to analyze the differences between groups